Since neddylation is frequently associated with malignant evolution in cancers, targeting the NEDD8 conjugation pathway through the inhibition of its activating enzyme by MLN4924 was developed as a new anticancer strategy [9, 34, 35]. Here, NEDD8 is linked to cancer.